Xiaoqing Wu

Title: Xiaoqing Wu: Inventor in Therapeutic Research

Introduction

Xiaoqing Wu is an inventor associated with Lawrence, Kansas, and research at the University of Kansas and the University of North Carolina. Wu is credited with 2 patents focused on therapeutic approaches involving RNA-binding proteins.

Latest Patents

Wu’s listed patents address compounds and treatment methods involving RNA-binding proteins:

- Inhibitors of RNA-Binding Proteins, Compositions Thereof, and Therapeutic Uses Thereof describes compounds intended to inhibit interactions between RNA-binding proteins and RNA, along with related intermediates, compositions, and potential treatment methods.

- Therapeutic Uses of Inhibitors of the RNA-Binding Protein HuR focuses on methods of treatment using inhibitors of HuR’s interaction with RNA.

Career Highlights

Wu’s work connects academic research with the development of potential therapeutic compounds. The listed patent technologies center on disrupting RNA-protein interactions, including those involving HuR.

Collaborations

Wu’s listed collaborators include Liang Xu and Lan Lan. The associated institutions include the University of Kansas and the University of North Carolina.

Conclusion

Xiaoqing Wu’s two listed patents reflect research into RNA-binding protein inhibitors and their potential therapeutic applications.